Company Filing History:
Years Active: 2020
Title: Erica Johansson: Innovator in Factor VIII Manufacturing
Introduction
Erica Johansson is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of biotechnology, particularly in the manufacturing of Factor VIII products for hemophilia treatment. Her innovative approach has led to advancements that improve the efficacy and safety of these critical therapies.
Latest Patents
Erica Johansson holds a patent for a process that enhances the manufacturing of Factor VIII, specifically focusing on achieving an improved ratio of FVIII:C/FVIII:Ag. This process utilizes chromatography techniques, including affinity chromatography with a specialized resin that binds Factor VIII. The resulting Factor VIII product boasts a monomer content of over 98%, which is crucial for effective hemophilia treatment while minimizing the risk of inhibitor formation.
Career Highlights
Johansson's career is marked by her dedication to advancing medical treatments through innovative processes. Her work at Octapharma AG has positioned her as a key player in the biotechnology sector, where she continues to push the boundaries of what is possible in Factor VIII production.
Collaborations
Throughout her career, Erica has collaborated with notable colleagues, including Stefan Winge and Marina Dadaian. These partnerships have fostered a collaborative environment that enhances research and development efforts within her field.
Conclusion
Erica Johansson's contributions to the biotechnology industry, particularly in the manufacturing of Factor VIII, highlight her role as an influential inventor. Her innovative processes not only improve treatment outcomes for hemophilia patients but also set new standards in the field.